AZN stock news
This page provides real-time market news, earnings updates, and company announcements related to AstraZeneca PLC (AZN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-23 11:20 GMT
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca
Finviz2026-03-05 22:39:45
Will Linzess Keep Boosting IRWD's Revenue in 2026 Following a Weak Fourth Quarter?
101 finance2026-03-06 14:30:47
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
Finviz2026-03-09 14:37:07
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
101 finance2026-03-09 17:48:37
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
AstraZeneca's Stock Ranks 395th in Trading Activity Amid Institutional Splits and 156% Dividend Yield
101 finance2026-03-11 00:48:45
Mr. Duan has also invested in AI
金融界2026-03-11 10:21:44
US and Global Stocks: Is the Divide Shrinking?
101 finance2026-03-11 15:21:48
Building materials conglomerate exits London stock exchange
101 finance2026-03-16 12:09:45
Can Merck’s Latest Medications and Development Pipeline Address Worries About Keytruda’s Loss of Exclusivity?
101 finance2026-03-16 15:10:06
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
AbbVie Falls Under 50-Day SMA: Should You Buy, Sell, or Hold?
101 finance2026-03-17 16:48:51
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
Finviz2026-03-18 11:48:47
J&J versus Merck: Crucial Considerations Investors Should Evaluate at This Moment
101 finance2026-03-18 15:16:08
PFE's Atirmociclib Second-Line Breast Cancer Trial Achieves Target, Supports Pipeline Advancement
101 finance2026-03-18 16:31:27
Incyte’s MutCALR Bet: S-Curve Inflection in MPN Infrastructure
101 finance2026-03-19 16:51:58
AstraZeneca’s China CKD Registry Could Fast-Track Nephrology Market Access via Real-World Evidence Edge
101 finance2026-03-19 16:57:42
2 Healthcare Shares to Consider Purchasing Before Potential Buyouts
101 finance2026-03-20 10:06:38
2 Healthcare Shares to Consider Purchasing Before Potential Buyouts
101 finance2026-03-20 10:18:37
Cellectis’ Pivotal Study Timelines and Milestone Eligibility Clash in 2025 Q4 Earnings Call
101 finance2026-03-20 17:16:00
Cellectis Reports Net Loss Surging by 544% Even as Trial Outcomes Show Promise
101 finance2026-03-21 07:12:46
AstraZeneca’s shares fell 9.44% this month, but the market is overlooking its $15 billion investment in China—recent volatility is an overreaction to short-term developments.
101 finance2026-03-22 15:06:47
HUTCHMED’s HMPL-760 Addresses BTK Mutation Resistance in China’s Rapidly Expanding Cancer Market
101 finance2026-03-23 00:33:44
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
AstraZeneca's Stock Ranks 395th in Trading Activity Amid Institutional Splits and 156% Dividend Yield
101 finance2026-03-11 00:48:45
Mr. Duan has also invested in AI
金融界2026-03-11 10:21:44
US and Global Stocks: Is the Divide Shrinking?
101 finance2026-03-11 15:21:48
Building materials conglomerate exits London stock exchange
101 finance2026-03-16 12:09:45
Can Merck’s Latest Medications and Development Pipeline Address Worries About Keytruda’s Loss of Exclusivity?
101 finance2026-03-16 15:10:06
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
AbbVie Falls Under 50-Day SMA: Should You Buy, Sell, or Hold?
101 finance2026-03-17 16:48:51
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
Finviz2026-03-18 11:48:47
J&J versus Merck: Crucial Considerations Investors Should Evaluate at This Moment
101 finance2026-03-18 15:16:08
PFE's Atirmociclib Second-Line Breast Cancer Trial Achieves Target, Supports Pipeline Advancement
101 finance2026-03-18 16:31:27
Incyte’s MutCALR Bet: S-Curve Inflection in MPN Infrastructure
101 finance2026-03-19 16:51:58
AstraZeneca’s China CKD Registry Could Fast-Track Nephrology Market Access via Real-World Evidence Edge
101 finance2026-03-19 16:57:42
2 Healthcare Shares to Consider Purchasing Before Potential Buyouts
101 finance2026-03-20 10:06:38
2 Healthcare Shares to Consider Purchasing Before Potential Buyouts
101 finance2026-03-20 10:18:37
Cellectis’ Pivotal Study Timelines and Milestone Eligibility Clash in 2025 Q4 Earnings Call
101 finance2026-03-20 17:16:00
Cellectis Reports Net Loss Surging by 544% Even as Trial Outcomes Show Promise
101 finance2026-03-21 07:12:46
AstraZeneca’s shares fell 9.44% this month, but the market is overlooking its $15 billion investment in China—recent volatility is an overreaction to short-term developments.
101 finance2026-03-22 15:06:47
HUTCHMED’s HMPL-760 Addresses BTK Mutation Resistance in China’s Rapidly Expanding Cancer Market
101 finance2026-03-23 00:33:44
AZN stock price change
On the last trading day, AZN stock closed at 13896.00 GBP, with a price change of -1.53% for the day.
Trade stock perpsAZN stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more